Aeovian - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAeovian
Aeovian logo

Aeovian

0 followers

About Aeovian

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Davis C. Ryman, MD, PhD

Chief Medical Officer

Allison J. Hulme, PhD

Chief Executive Officer

Micah Zajic

Chief Financial Officer

John F. Kincaid

Chief Scientific Officer

Key Facts

HQ Location

Berkeley, United States

Founded

2012

Employees

11 - 50

Status

Private

Website

https://aeovian.com